Period | Weighting | Quarter | ||||||
---|---|---|---|---|---|---|---|---|
Company | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
MILLENNIUM MANAGEMENT LLC | 8 | 8 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q1 2018 | 8 |
Cormorant Asset Management, LP | 8 | 8 | 0.00% | 0.02% | 0.06% | Q2 2016 | Q1 2018 | 8 |
PointState Capital LP | 8 | 8 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q1 2018 | 8 |
UBS Group AG | 8 | 8 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q1 2018 | 8 |
Monashee Investment Management LLC | 8 | 8 | 0.00% | 0.01% | 0.02% | Q2 2016 | Q1 2018 | 8 |
Avoro Capital Advisors LLC | 8 | 8 | 0.00% | 0.02% | 0.04% | Q2 2016 | Q1 2018 | 8 |
MORGAN STANLEY | 8 | 8 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q1 2018 | 8 |
SABBY MANAGEMENT, LLC | 7 | 7 | 0.00% | 0.02% | 0.05% | Q2 2016 | Q4 2017 | 7 |
ACUTA CAPITAL PARTNERS, LLC | 6 | 6 | 0.00% | 0.02% | 0.04% | Q2 2016 | Q3 2017 | 6 |
Marshall Wace North America L.P. | 5 | 5 | 0.00% | 0.00% | 0.00% | Q1 2017 | Q1 2018 | 5 |
Perceptive Advisors | 5 | 5 | 0.00% | 0.02% | 0.05% | Q2 2016 | Q2 2017 | 5 |
Jefferies Group LLC | 3 | 3 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q4 2016 | 3 |
MARSHALL WACE, LLP | 3 | 3 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q4 2016 | 3 |
MARSHALL WACE ASIA Ltd | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2017 | Q1 2017 | 1 |
Tower Research Capital LLC (TRC) | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q2 2016 | 1 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2018 | Q1 2018 | 1 |
Virtu Financial LLC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2017 | Q3 2017 | 1 |
Hudson Bay Capital Management LP | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2016 | Q2 2016 | 1 |
Virtu KCG Holdings LLC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2017 | Q2 2017 | 1 |
External links
This page lists all the filers that currently own ONCOBIOLOGICS INC or have owned ONCOBIOLOGICS INC in the past.